申请人:LILLY CO ELI
公开号:WO2013188184A1
公开(公告)日:2013-12-19
The present invention provides an amino pyrazole compound, which is 3-[(lR)-6-fluoro-2,3-dihydro-1H-inden-l-yl]-N-(3- methyl-IH- pyrazol-5-yl)-3H-imidazo[4,5-b]pyridin-5-amine, or a pharmaceutically acceptable salt thereof, that inhibits JAK1 and JAK2 and, therefore may be useful in treating cancer.
本发明提供了一种氨基吡唑化合物,即3-[(lR)-6-氟-2,3-二氢-1H-茚-1-基]-N-(3-甲基-1H-吡唑-5-基)-3H-咪唑并[4,5-b]吡啶-5-胺,或其药学上可接受的盐,该化合物抑制JAK1和JAK2,因此可能在治疗癌症方面有用。